SCHEMBL25343113

SCHEMBL25343113

CS(=O)(=O)N(c1ccc(-c2nccnc2Oc2ccc(C(F)(F)F)cc2)cc1F)S(C)(=O)=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 3/20 0.35
▸ TRPV1 Q8NER1 3/20 0.35
▸ KIF11 P52732 3/20 0.34
▸ ALOX5AP P20292 2/20 0.34
▸ FEN1 P39748 2/20 0.34
▸ SLC6A2 P23975 1/20 0.34
▸ SLC6A4 P31645 1/20 0.34
▸ SLC6A3 Q01959 1/20 0.34
▸ PTGS1 P23219 1/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ PDE10A Q9Y233 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ CASP3 P42574 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ SENP8 Q96LD8 1/20 0.33
▸ SENP7 Q9BQF6 1/20 0.33
▸ SENP6 Q9GZR1 1/20 0.33
▸ MMP2 P08253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30519319 1.00 PTGS2 (0.35) PTGS2TRPV1KIF11ALOX5APFEN1
SCHEMBL30519311 0.88 SLC6A2 (0.36) PTGS2KIF11ALOX5APFEN1SLC6A2
SCHEMBL25341461 0.88 SLC6A2 (0.36) PTGS2KIF11ALOX5APFEN1SLC6A2
SCHEMBL25975488 0.84 PDE10A (0.35) TRPV1PDE10AALDH1A1NPC1CASP3
SCHEMBL30519400 0.81 KIF11 (0.48) TRPV1KIF11SLC6A2SLC6A4SLC6A3
SCHEMBL25341619 0.81 KIF11 (0.48) TRPV1KIF11SLC6A2SLC6A4SLC6A3
SCHEMBL25971711 0.78 KIF11 (0.45) TRPV1KIF11ALOX5APFEN1SLC6A2
SCHEMBL25378347 0.77 LMNA (0.41) SMN1; SMN2LMNAALDH1A1
SCHEMBL30482519 0.77 LMNA (0.41) SMN1; SMN2LMNAALDH1A1
SCHEMBL25340813 0.77 KCNH2 (0.38) TRPV1ALOX5APFEN1LMNAPDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146513-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback